Washington (HRNW) US biotech firm Moderna has announced that it will file requests for authorization of its Covid-19 vaccine in the United States and Europe on Monday, after full results confirmed a high efficacy estimated at 94.1%.
“Moderna plans today to request EUA [Emergency Use Authorization] from the US FDA [Food and Drug Administration],” Moderna said in a statement, adding that it will also “apply for a conditional marketing authorisation with the European Medicines Agency.”
The US, the country worst affected by the virus, hopes to start COVID-19 vaccinations on around 20 million people by this year’s end.
On November 16, Moderna had announced that its experimental vaccine against COVID-19 was 94.5% effective, according to early results from a clinical trial with more than 30,000 participants.
Be the first to comment on "Moderna will request US, Europe for coronavirus vaccine authorisation"